A detailed history of Wedbush Securities Inc transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Wedbush Securities Inc holds 28,404 shares of TEVA stock, worth $497,070. This represents 0.02% of its overall portfolio holdings.

Number of Shares
28,404
Previous 31,842 10.8%
Holding current value
$497,070
Previous $449,000 2.9%
% of portfolio
0.02%
Previous 0.02%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$12.78 - $17.4 $43,937 - $59,821
-3,438 Reduced 10.8%
28,404 $462,000
Q1 2024

May 14, 2024

BUY
$10.67 - $14.43 $43,757 - $59,177
4,101 Added 14.78%
31,842 $449,000
Q4 2023

Feb 12, 2024

SELL
$8.12 - $10.63 $6,292 - $8,238
-775 Reduced 2.72%
27,741 $290,000
Q3 2023

Nov 14, 2023

SELL
$7.48 - $10.7 $38,177 - $54,612
-5,104 Reduced 15.18%
28,516 $291,000
Q2 2023

Aug 14, 2023

SELL
$7.2 - $9.47 $9,360 - $12,311
-1,300 Reduced 3.72%
33,620 $253,000
Q1 2023

May 09, 2023

SELL
$8.36 - $11.37 $6,955 - $9,459
-832 Reduced 2.33%
34,920 $309,000
Q4 2022

Jan 31, 2023

SELL
$7.95 - $9.48 $42,135 - $50,244
-5,300 Reduced 12.91%
35,752 $326,000
Q3 2022

Oct 18, 2022

BUY
$6.86 - $11.95 $20,923 - $36,447
3,050 Added 8.03%
41,052 $331,000
Q2 2022

Jul 21, 2022

SELL
$7.38 - $10.4 $1,845 - $2,600
-250 Reduced 0.65%
38,002 $285,000
Q1 2022

Apr 19, 2022

SELL
$7.33 - $9.39 $1,099 - $1,408
-150 Reduced 0.39%
38,252 $359,000
Q4 2021

Jan 13, 2022

SELL
$7.9 - $10.19 $3,160 - $4,076
-400 Reduced 1.03%
38,402 $307,000
Q3 2021

Oct 08, 2021

SELL
$8.38 - $10.18 $15,503 - $18,833
-1,850 Reduced 4.55%
38,802 $377,000
Q2 2021

Jul 27, 2021

SELL
$9.9 - $11.56 $2,039 - $2,381
-206 Reduced 0.5%
40,652 $402,000
Q1 2021

Apr 26, 2021

BUY
$10.34 - $12.81 $101,197 - $125,371
9,787 Added 31.5%
40,858 $471,000
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $31,486 - $40,373
-3,657 Reduced 10.53%
31,071 $300,000
Q3 2020

Oct 20, 2020

SELL
$8.57 - $12.69 $21,904 - $32,435
-2,556 Reduced 6.86%
34,728 $313,000
Q2 2020

Jul 16, 2020

SELL
$8.12 - $13.12 $117,025 - $189,085
-14,412 Reduced 27.88%
37,284 $460,000
Q1 2020

Apr 17, 2020

BUY
$6.69 - $13.45 $13,761 - $27,666
2,057 Added 4.14%
51,696 $464,000
Q4 2019

Jan 16, 2020

BUY
$6.53 - $10.72 $47,616 - $78,170
7,292 Added 17.22%
49,639 $486,000
Q3 2019

Oct 17, 2019

BUY
$6.16 - $9.6 $64,082 - $99,868
10,403 Added 32.57%
42,347 $291,000
Q2 2019

Aug 01, 2019

BUY
$8.12 - $15.72 $28,899 - $55,947
3,559 Added 12.54%
31,944 $295,000
Q1 2019

Apr 17, 2019

BUY
$15.58 - $20.01 $15,813 - $20,310
1,015 Added 3.71%
28,385 $445,000
Q4 2018

Jan 31, 2019

SELL
$14.59 - $23.84 $52,888 - $86,420
-3,625 Reduced 11.7%
27,370 $422,000
Q3 2018

Nov 13, 2018

SELL
$21.06 - $25.65 $32,642 - $39,757
-1,550 Reduced 4.76%
30,995 $668,000
Q2 2018

Aug 03, 2018

SELL
$16.77 - $24.71 $267,900 - $394,742
-15,975 Reduced 32.92%
32,545 $791,000
Q1 2018

May 01, 2018

SELL
$16.68 - $22.07 $524,285 - $693,704
-31,432 Reduced 39.31%
48,520 $829,000
Q4 2017

Feb 09, 2018

SELL
$11.23 - $19.1 $191,168 - $325,139
-17,023 Reduced 17.55%
79,952 $1.52 Million
Q3 2017

Oct 31, 2017

BUY
$15.41 - $32.17 $1.49 Million - $3.12 Million
96,975
96,975 $1.71 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.4B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Wedbush Securities Inc Portfolio

Follow Wedbush Securities Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wedbush Securities Inc with notifications on news.